SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001019687-09-000828
Filing Date
2009-03-13
Accepted
2009-03-13 16:37:06
Documents
1
Period of Report
2009-03-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 8189
  Complete submission text file 0001019687-09-000828.txt   10162
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Issuer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 714-508-6000
Shan Joseph (Reporting) CIK: 0001457697 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32839 | Film No.: 09680583